Kingfa Science & Technology (India) (KINGFA)₹6,166+2.69%Plastic Products - Industrial
In the Mar 2026 quarter (standalone), Kingfa Science & Technology (India) reported sales of ₹580 Cr, up 23.1% from Mar 2025, and net profit of ₹59.18 Cr, up 40.5% year on year. For the year to Mar 2026, sales were ₹2,004 Cr and net profit ₹186 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 340 | 352 | 395 | 405 | 418 | 420 | 442 | 471 | 464 | 467 | 490 | 580 |
| Expenses | 288 | 306 | 355 | 353 | 359 | 361 | 388 | 408 | 403 | 404 | 428 | 496 |
| Operating Profit | 50.03 | 44.99 | 38.04 | 51.06 | 57.05 | 56.06 | 51.02 | 59.99 | 58.05 | 61.03 | 62.01 | 81.11 |
| OPM % | 15.0% | 13.0% | 10.0% | 13.0% | 14.0% | 13.0% | 12.0% | 13.0% | 13.0% | 13.0% | 13.0% | 14.0% |
| Other Income | 1.99 | 0.00 | 1.01 | 2.01 | 2.01 | 0.99 | 5.01 | 2.01 | 3.99 | 2.99 | 6.99 | 7.01 |
| Interest | 1.01 | 1.01 | 1.01 | 2.01 | 1.01 | 1.01 | 1.01 | 2.01 | 1.01 | 1.01 | 1.01 | 1.01 |
| Depreciation | 4.01 | 4.01 | 5.01 | 5.01 | 5.01 | 5.01 | 5.01 | 6.01 | 6.01 | 7.02 | 7.02 | 8.02 |
| Profit before tax | 47.09 | 40.05 | 32.05 | 45.10 | 52.10 | 50.07 | 49.06 | 54.07 | 54.06 | 55.08 | 61.15 | 80.12 |
| Tax % | 25.0% | 25.0% | 25.1% | 26.1% | 25.0% | 26.0% | 30.1% | 23.0% | 26.0% | 26.1% | 26.1% | 26.0% |
| Net Profit | 35.13 | 30.11 | 24.08 | 34.09 | 39.10 | 37.11 | 35.11 | 42.12 | 40.15 | 41.11 | 45.16 | 59.18 |
| EPS (Rs) | 28.94 | 24.45 | 20.11 | 27.73 | 32.30 | 30.80 | 28.62 | 34.59 | 32.90 | 30.39 | 33.34 | 43.70 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 315 | 428 | 604 | 704 | 744 | 629 | 1,052 | 1,408 | 1,493 | 1,750 | 2,004 | 2,002 |
| Expenses | 287 | 407 | 559 | 665 | 697 | 606 | 964 | 1,273 | 1,301 | 1,517 | 1,730 | 1,730 |
| Operating Profit | 27.01 | 19.01 | 41.03 | 35.03 | 43.01 | 20.01 | 82.01 | 128 | 185 | 225 | 261 | 262 |
| OPM % | 8.0% | 4.5% | 7.0% | 5.0% | 6.0% | 3.2% | 8.0% | 9.0% | 12.0% | 13.0% | 13.0% | 13.1% |
| Other Income | 1.01 | 4.01 | 6.01 | 4.01 | 2.99 | 5.99 | −21.99 | 1.99 | 3.01 | 9.01 | 21.01 | 20.98 |
| Interest | 7.02 | 2.01 | 2.01 | 2.01 | 4.01 | 3.01 | 5.01 | 7.02 | 6.01 | 7.02 | 4.01 | 4.04 |
| Depreciation | 3.01 | 3.01 | 6.01 | 8.02 | 9.02 | 11.03 | 13.03 | 14.04 | 18.05 | 22.05 | 28.08 | 28.07 |
| Profit before tax | 17.02 | 18.03 | 39.07 | 29.05 | 33.07 | 12.02 | 41.05 | 110 | 164 | 206 | 250 | 250 |
| Tax % | 38.0% | 30.0% | 36.0% | 35.0% | 26.0% | 55.1% | 26.1% | 26.0% | 25.1% | 26.0% | 26.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −16.94 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | 11.03 | 12.04 | 25.09 | 19.07 | 25.08 | 5.01 | 31.12 | 81.20 | 123 | 153 | 186 | 186 |
| EPS (Rs) | 8.94 | 10.25 | 20.37 | 15.73 | 20.34 | 4.40 | 25.30 | 67.23 | 101.28 | 126.21 | 136.88 | 140.33 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 10.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.99 | 9.98 | 9.98 | 11.97 | 11.98 | 11.97 | 11.98 | 11.97 | 11.98 | 11.98 | 11.98 | 13.97 |
| Reserves | 2.01 | 109 | 235 | 294 | 313 | 337 | 343 | 373 | 455 | 578 | 717 | 1,388 |
| Borrowings | 74.84 | 15.97 | 41.91 | 20.94 | 16.97 | 45.86 | 70.79 | 45.88 | 41.86 | 32.94 | 42.92 | 14.97 |
| Other Liabilities | 41.20 | 94.86 | 119 | 158 | 210 | 202 | 246 | 449 | 501 | 372 | 383 | 338 |
| Total Liabilities | 125 | 230 | 405 | 485 | 552 | 596 | 671 | 881 | 1,010 | 995 | 1,156 | 1,755 |
| Fixed Assets | 25.05 | 29.07 | 76.12 | 88.15 | 85.19 | 107 | 129 | 126 | 123 | 252 | 245 | 300 |
| CWIP | 1.01 | 41.11 | 10.01 | 2.01 | 79.11 | 115 | 123 | 127 | 131 | 2.01 | 41.11 | 61.07 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 98.98 | 160 | 319 | 395 | 388 | 375 | 419 | 627 | 756 | 740 | 871 | 1,393 |
| Inventories | 32.09 | 59.15 | 69.19 | 116 | 103 | 111 | 143 | 262 | 290 | 243 | 302 | 325 |
| Trade receivables | 55.88 | 84.74 | 130 | 181 | 210 | 197 | 212 | 283 | 357 | 403 | 445 | 533 |
| Cash & equivalents | 0.00 | 7.01 | 104 | 71.09 | 53.09 | 23.05 | 24.05 | 29.07 | 24.04 | 5.01 | 24.04 | 422 |
| Total Assets | 125 | 230 | 405 | 485 | 552 | 596 | 671 | 881 | 1,010 | 995 | 1,156 | 1,755 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | −0.99 | 18.95 | −119 | −116 | 95.68 | 29.90 | −1.99 | 37.90 | 26.93 | 15.95 | 59.81 | 65.78 |
| Cash from investing activity | −3.99 | −46.94 | −17.97 | −5.99 | −76.90 | −62.88 | −13.98 | −18.98 | −11.98 | 1.99 | −29.94 | −391 |
| Cash from financing activity | 5.01 | 34.06 | 137 | 14.02 | −7.02 | 22.04 | 17.03 | −14.03 | −21.04 | −8.02 | −7.01 | 439 |
| Net cash flow | 0.00 | 6.02 | −1.01 | −108 | 12.04 | −11.03 | 1.01 | 5.01 | −6.01 | 10.03 | 23.06 | 112 |
| Capex | 4.01 | 48.01 | 19.01 | 11.01 | 82.02 | 66.06 | 15.01 | 19.01 | 25.03 | 21.01 | 29.99 | 111 |
| Free cash flow | −4.99 | −27.91 | −138 | −127 | 13.96 | −34.89 | −16.96 | 18.94 | 2.99 | −4.99 | 29.91 | −44.88 |
| CFO / OP % | −13.0% | 72.1% | −602.0% | −256.0% | 300.1% | 111.1% | 5.0% | 63.0% | 35.0% | 29.0% | 56.1% | 48.1% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 93 | 99 | 111 | 110 | 109 | 97 | 123 | 99 | 93 | 99 | 93 | 98 |
| Inventory days | 63 | 84 | 68 | 84 | 62 | 66 | 99 | 109 | 93 | 75 | 81 | 77 |
| Days payable | 71 | 126 | 107 | 107 | 118 | 114 | 151 | 180 | 154 | 109 | 93 | 74 |
| Cash conversion cycle | 84 | 56 | 71 | 85 | 52 | 48 | 70 | 27 | 31 | 65 | 79 | 99 |
| Working capital days | −14 | 66 | 59 | 96 | 59 | 55 | 57 | 39 | 45 | 78 | 85 | 113 |
| ROCE % | 4.0% | 22.0% | 9.0% | 13.0% | 9.0% | 9.9% | 4.0% | 16.0% | 25.0% | 29.9% | 31.0% | 22.9% |
For the Mar 2026 quarter, Kingfa Science & Technology (India) reported sales of ₹580 Cr, up 23.1% year on year and net profit of ₹59.18 Cr, up 40.5% year on year. The operating margin was 14.0%.
Kingfa Science & Technology (India)'s sales for the year to Mar 2026 were ₹2,004 Cr; over the last twelve months they were ₹2,002 Cr.
Net profit for the year to Mar 2026 was ₹186 Cr, and ₹186 Cr over the last twelve months. Earnings per share over the same trailing period were ₹140.33.
Kingfa Science & Technology (India) reported borrowings of ₹14.97 Cr at Mar 2026, against cash and equivalents of ₹422 Cr.
Cash from operations was ₹65.78 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹44.88 Cr.